Principal Financial Group’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.4M | Sell |
1,466,875
-106,481
| -7% | -$3.15M | 0.02% | 508 |
|
|
2025
Q1 | $47M | Sell |
1,573,356
-71,695
| -4% | -$2.14M | 0.03% | 461 |
|
|
2024
Q4 | $47.1M | Sell |
1,645,051
-100,767
| -6% | -$2.89M | 0.03% | 480 |
|
|
2024
Q3 | $67.5M | Buy |
1,745,818
+64,958
| +4% | +$2.51M | 0.04% | 382 |
|
|
2024
Q2 | $54.1M | Buy |
1,680,860
+128,003
| +8% | +$4.12M | 0.03% | 430 |
|
|
2024
Q1 | $60.3M | Sell |
1,552,857
-16,294
| -1% | -$633K | 0.04% | 417 |
|
|
2023
Q4 | $48.3M | Sell |
1,569,151
-10,089
| -0.6% | -$311K | 0.03% | 456 |
|
|
2023
Q3 | $35.3M | Sell |
1,579,240
-4,053
| -0.3% | -$90.6K | 0.03% | 524 |
|
|
2023
Q2 | $34M | Buy |
1,583,293
+32,255
| +2% | +$693K | 0.02% | 566 |
|
|
2023
Q1 | $37.2M | Sell |
1,551,038
-120,029
| -7% | -$2.88M | 0.03% | 524 |
|
|
2022
Q4 | $38.8M | Sell |
1,671,067
-91,533
| -5% | -$2.12M | 0.03% | 493 |
|
|
2022
Q3 | $28.2M | Buy |
1,762,600
+24,309
| +1% | +$389K | 0.02% | 570 |
|
|
2022
Q2 | $30.8M | Buy |
1,738,291
+320,778
| +23% | +$5.68M | 0.02% | 571 |
|
|
2022
Q1 | $28.9M | Buy |
1,417,513
+111,770
| +9% | +$2.28M | 0.02% | 689 |
|
|
2021
Q4 | $24.4M | Buy |
1,305,743
+248,132
| +23% | +$4.64M | 0.01% | 808 |
|
|
2021
Q3 | $20.9M | Buy |
1,057,611
+25,684
| +2% | +$507K | 0.01% | 911 |
|
|
2021
Q2 | $24.4M | Buy |
1,031,927
+323,854
| +46% | +$7.66M | 0.02% | 811 |
|
|
2021
Q1 | $16.8M | Buy |
708,073
+333,737
| +89% | +$7.91M | 0.01% | 1065 |
|
|
2020
Q4 | $7.5M | Buy |
+374,336
| New | +$7.5M | 0.01% | 1383 |
|